Dongrui Wang

3.8k total citations · 2 hit papers
39 papers, 1.9k citations indexed

About

Dongrui Wang is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Dongrui Wang has authored 39 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 15 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Dongrui Wang's work include CAR-T cell therapy research (31 papers), Viral Infectious Diseases and Gene Expression in Insects (10 papers) and Immune Cell Function and Interaction (9 papers). Dongrui Wang is often cited by papers focused on CAR-T cell therapy research (31 papers), Viral Infectious Diseases and Gene Expression in Insects (10 papers) and Immune Cell Function and Interaction (9 papers). Dongrui Wang collaborates with scholars based in United States, China and France. Dongrui Wang's co-authors include Christine E. Brown, Xianlin Wu, Yingli Sun, Darya Alizadeh, Stephen J. Forman, Renate Starr, Brenda Aguilar, Xin Yang, Alfonso Brito and Joseph R. Pecoraro and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Dongrui Wang

36 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype

2019 324 citations Darya Alizadeh, Robyn A. Wong et al. Cancer Immunology Research profile →
Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response

2022 312 citations Dongrui Wang, Xianlin Wu et al. Signal Transduction and Targeted Therapy profile →

Peers

Dongrui Wang

ONCOL

IMMUN

GENET

Rosalie M. Sterner United States

Robert C. Sterner United States

Selene Nuñez-Cruz United States

Bizhi Shi China

Mark B. Leick United States

Giedre Krenciute United States

Evripidis Lanitis Switzerland

Meera Murgai United States

Liza B. John Australia

Rosalie M. Sterner United States

Dongrui Wang

1.4k ×1.0

ONCOL

676 ×1.0

805 ×1.2

IMMUN

492 ×1.0

342 ×1.2

GENET

Citations per year, relative to Dongrui Wang Dongrui Wang (= 1×) peers Rosalie M. Sterner

Countries citing papers authored by Dongrui Wang

Since Specialization

Citations

This map shows the geographic impact of Dongrui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongrui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongrui Wang more than expected).

Fields of papers citing papers by Dongrui Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongrui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongrui Wang. The network helps show where Dongrui Wang may publish in the future.

Co-authorship network of co-authors of Dongrui Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Dongrui Wang. A scholar is included among the top collaborators of Dongrui Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongrui Wang. Dongrui Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barish, Michael E., Maryam Aftabizadeh, M. Suzette Blanchard, et al.. (2025). Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safety. Cell Reports Medicine. 6(8). 102302–102302. 2 indexed citations

Sun, Xiaoyang, et al.. (2025). Circadian rhythm in immunotherapy and cellular therapy: impacts on the tumor microenvironment. Acta Biochimica et Biophysica Sinica. 58(1). 90–105.

Yang, Xue, et al.. (2024). Nonadiabatic dynamical simulations to the radiative recombination of nonfullerene acceptor molecular excited states. Optics Letters. 49(21). 6077–6077.

Liu, Xiao‐Lan, Xufeng Cen, Ziyan Chen, et al.. (2023). ARIH1 activates STING-mediated T-cell activation and sensitizes tumors to immune checkpoint blockade. Nature Communications. 14(1). 4066–4066. 30 indexed citations

Liu, Zongzhi, Yibo Gao, Jiejie Liu, et al.. (2023). Epigenetic reprogramming of Runx3 reinforces CD8 + T-cell function and improves the clinical response to immunotherapy. Molecular Cancer. 22(1). 84–84. 31 indexed citations

Yang, Yan, Minjie Wang, Feng Gao, et al.. (2023). The Effect and Mechanism of Syringa pinnatifolia Hemsl. Ligans on Cerebral Ischemia-Reperfusion Injury and Oxidative Stress in Mice. Neurochemical Research. 48(6). 1822–1834. 5 indexed citations

Zhang, Mingming, Guoqing Wei, Linghui Zhou, et al.. (2023). GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial. The Lancet Haematology. 10(2). e107–e116. 91 indexed citations

Sahoo, Prativa, et al.. (2023). Modeling interaction of Glioma cells and CAR T-cells considering multiple CAR T-cells bindings. SHILAP Revista de lepidopterología. 9. 100022–100022. 10 indexed citations

Luo, Yi, Lei Gao, Jia Liu, et al.. (2023). Donor-derived Anti-CD19 CAR T cells GC007g for relapsed or refractory B-cell acute lymphoblastic leukemia after allogeneic HSCT: a phase 1 trial. EClinicalMedicine. 67. 102377–102377. 9 indexed citations

10.

Wang, Dongrui, et al.. (2022). Potency monitoring of CAR T cells. Methods in cell biology. 173. 173–189.

11.

Wang, Dongrui, Xianlin Wu, & Yingli Sun. (2022). Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response. Signal Transduction and Targeted Therapy. 7(1). 331–331. 312 indexed citations breakdown →

12.

Alizadeh, Darya, Robyn A. Wong, Sharareh Gholamin, et al.. (2021). IFNγ Is Critical for CAR T Cell–Mediated Myeloid Activation and Induction of Endogenous Immunity. Cancer Discovery. 11(9). 2248–2265. 103 indexed citations

13.

Badie, Behnam, Michael E. Barish, Ammar Chaudhry, et al.. (2021). A phase 1 study to evaluate chimeric antigen receptor (CAR) T cells incorporating a chlorotoxin tumor-targeting domain for patients with MMP2+ Recurrent or progressive glioblastoma (NCT04214392).. Journal of Clinical Oncology. 39(15_suppl). TPS2662–TPS2662. 9 indexed citations

14.

Wang, Dongrui, Briana C. Prager, Ryan C. Gimple, et al.. (2020). CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based Therapies. Cancer Discovery. 11(5). 1192–1211. 121 indexed citations

15.

Sahoo, Prativa, Xin Yang, Daniel Abler, et al.. (2020). Mathematical deconvolution of CAR T-cell proliferation and exhaustion from real-time killing assay data. Journal of The Royal Society Interface. 17(162). 20190734–20190734. 68 indexed citations

16.

Alizadeh, Darya, Robyn A. Wong, Xin Yang, et al.. (2019). IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype. Cancer Immunology Research. 7(5). 759–772. 324 indexed citations breakdown →

17.

Wang, Dongrui, Renate Starr, Darya Alizadeh, et al.. (2019). In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function. Journal of Visualized Experiments. 16 indexed citations

18.

Wang, Dongrui, Brenda Aguilar, Renate Starr, et al.. (2018). Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity. JCI Insight. 3(10). 162 indexed citations

19.

Portnow, Jana, Timothy W. Synold, Vivian Chiu, et al.. (2018). ATIM-17. PEMBROLIZUMAB BLOCKS PD-1 ON CAR T CELLS ADMINISTERED INTRAVENTRICULARLY TO GLIOBLASTOMA PATIENTS. Neuro-Oncology. 20(suppl_6). vi4–vi4. 1 indexed citations

20.

Xiao, Lu, Xiaoying Lan, Xianping Shi, et al.. (2017). Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer. Cell Death and Disease. 8(5). e2803–e2803. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact